Clinical Trial Update: Vargatef in Addition to First Line Chemotherapy With Interval Debulking Surgery in Patients With Ovarian Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating vargatef added to first-line chemotherapy with interval debulking surgery in ovarian cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Vargatef

Snippet

Sponsor: ARCAGY/ GINECO GROUP | Conditions: Ovarian Cancer | Phase 2 | Status: COMPLETED